retatrutide clinical trial results safety Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Dosing Schedule for Retatrutide: Trial

doi: 10.3390/cells8020194 129 SuzukiT.MuramatsuA.SaitoR.IsoT.ShibataT.KuwataK.et al

Long-term efficacy and safety of canagliflozin over 104 weeks in patients aged 55-80 years with type 2 diabetes

In addition, several effects of incretin-based diabetes therapies beyond their glycemic-lowering properties via the endocrine pancreas have been described, including reduced immune cell infiltration and altered cytokine expression (66)

Type 2 diabetes is now one of the most common health conditions worldwide, and it continues to grow

Importance: Currently, endometriosis diagnosis is made by laparoscopic examination and histology report

Established Customer Base Track record matters in a market where many high-profile vendors have imploded